e-learning
resources
Vienna 2009
Monday, 14.09.2009
Assessment of severity in respiratory infections: severity scales and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Apache II score and prediction of ventilator-associated pneumonia (VAP)
P. Peyrani, T. Wiemken, P. Cabral, M. Gnoni, M. Luz Paz, M. Del Carmen Venero, J. Ramirez (Louisville, United States Of America)
Source:
Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Session:
Assessment of severity in respiratory infections: severity scales and biomarkers
Session type:
Thematic Poster Session
Number:
2373
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Peyrani, T. Wiemken, P. Cabral, M. Gnoni, M. Luz Paz, M. Del Carmen Venero, J. Ramirez (Louisville, United States Of America). Apache II score and prediction of ventilator-associated pneumonia (VAP). Eur Respir J 2009; 34: Suppl. 53, 2373
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005
Ventilator – associated pneumonia (VAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 547s
Year: 2004
CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Performance of CURB-65 and CURB-age in community acquired pneumonia (CAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007
The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
A new severity score for community-acquired pneumonia: PARB score
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Prediction of clinical severity and outcome of ventilator-associated pneumonia in a tertiary hospital using the VAP PIRO scoring system
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
GRACE: spreading knowledge about community-acquired pneumonia
Source: ISSN=ISSN 1810-6838, ISBN=, page=305
Year: 2006
Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept